Chiara Conti

1.3k total citations
28 papers, 965 citations indexed

About

Chiara Conti is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chiara Conti has authored 28 papers receiving a total of 965 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chiara Conti's work include DNA Repair Mechanisms (7 papers), Cancer therapeutics and mechanisms (4 papers) and Cancer-related Molecular Pathways (4 papers). Chiara Conti is often cited by papers focused on DNA Repair Mechanisms (7 papers), Cancer therapeutics and mechanisms (4 papers) and Cancer-related Molecular Pathways (4 papers). Chiara Conti collaborates with scholars based in Italy, United States and France. Chiara Conti's co-authors include Yves Pommier, Mirit I. Aladjem, Ali Syed, Olivier Sordet, Asako Nakamura, Josée Guirouilh‐Barbat, Gabriel S. Eichler, Aaron Bensimon, Melvenia M. Martin and Elisabetta Leo and has published in prestigious journals such as Molecular and Cellular Biology, Cancer Research and Journal of Controlled Release.

In The Last Decade

Chiara Conti

25 papers receiving 948 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiara Conti Italy 13 753 297 120 82 62 28 965
Raman Kumar Australia 16 618 0.8× 215 0.7× 151 1.3× 87 1.1× 242 3.9× 36 919
Matsuyuki Shirota Japan 16 586 0.8× 123 0.4× 94 0.8× 56 0.7× 172 2.8× 49 899
Xiaobing Tian United States 15 488 0.6× 138 0.5× 175 1.5× 114 1.4× 60 1.0× 37 754
Lynn S. Cheng Canada 7 421 0.6× 359 1.2× 95 0.8× 33 0.4× 33 0.5× 7 591
Yixue Gu China 19 802 1.1× 161 0.5× 453 3.8× 60 0.7× 51 0.8× 40 1.1k
Janice Rowe United Kingdom 13 524 0.7× 542 1.8× 106 0.9× 58 0.7× 31 0.5× 17 908
Teng Ji China 16 347 0.5× 190 0.6× 99 0.8× 62 0.8× 87 1.4× 29 642
Zuzanna Tracz‐Gaszewska Poland 8 382 0.5× 108 0.4× 173 1.4× 46 0.6× 24 0.4× 9 514
Enyuan Shang United States 17 921 1.2× 99 0.3× 201 1.7× 54 0.7× 190 3.1× 27 1.2k
Marta Deganuto Italy 15 644 0.9× 119 0.4× 52 0.4× 158 1.9× 59 1.0× 18 1.1k

Countries citing papers authored by Chiara Conti

Since Specialization
Citations

This map shows the geographic impact of Chiara Conti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Conti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Conti more than expected).

Fields of papers citing papers by Chiara Conti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Conti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Conti. The network helps show where Chiara Conti may publish in the future.

Co-authorship network of co-authors of Chiara Conti

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Conti. A scholar is included among the top collaborators of Chiara Conti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Conti. Chiara Conti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Conti, Chiara, Stefania Stella, Michele Massimino, et al.. (2025). Bridging the Gap: the role of MDM2 inhibition in overcoming treatment resistance in breast cancer. Critical Reviews in Oncology/Hematology. 214. 104834–104834. 1 indexed citations
2.
Saad, Everardo D., Giacomo Bregni, Valentina Daprà, et al.. (2024). 505P State of the art of gastrointestinal (GI) cancer trials for older patients (pts): A systematic review (SR). Annals of Oncology. 35. S201–S202. 1 indexed citations
3.
Lim, Sun Min, Stefanie S. Schalm, Sewon Park, et al.. (2024). BLU-945, a potent and selective next-generation EGFR TKI, has antitumor activity in models of osimertinib-resistant non-small-cell lung cancer. Therapeutic Advances in Medical Oncology. 16. 7 indexed citations
4.
Daprà, Valentina, et al.. (2024). Non-operative management after immune checkpoint inhibitors for early-stage, dMMR/MSI-H gastrointestinal cancers. Cancer Treatment Reviews. 128. 102752–102752. 3 indexed citations
5.
6.
Iliou, Maria S., et al.. (2022). BLU-945 or BLU-701 as single agents versus their combination with osimertinib in EGFR L858R driven tumor models. European Journal of Cancer. 174. S63–S63. 5 indexed citations
7.
Martin, Matthew W., Jennifer Y. Lee, David R. Lancia, et al.. (2018). Discovery of novel N-hydroxy-2-arylisoindoline-4-carboxamides as potent and selective inhibitors of HDAC11. Bioorganic & Medicinal Chemistry Letters. 28(12). 2143–2147. 41 indexed citations
8.
Sonvico, Fabio, Chiara Conti, Gaia Colombo, et al.. (2017). Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect. Journal of Controlled Release. 262. 296–304. 10 indexed citations
9.
Berardis, Domenico De, Laura Orsolini, Felice Iasevoli, et al.. (2016). The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders. Current Pharmaceutical Design. 22(33). 5144–5162. 21 indexed citations
10.
Conti, Chiara, Elisabetta Leo, Gabriel S. Eichler, et al.. (2010). Inhibition of Histone Deacetylase in Cancer Cells Slows Down Replication Forks, Activates Dormant Origins, and Induces DNA Damage. Cancer Research. 70(11). 4470–4480. 126 indexed citations
11.
McNeely, Samuel, Chiara Conti, Tahir Sheikh, et al.. (2010). Chk1 inhibition after replicative stress activates a double strand break response mediated by ATM and DNA-dependent protein kinase. Cell Cycle. 9(5). 995–1004. 68 indexed citations
12.
Sordet, Olivier, Christophe E. Redon, Josée Guirouilh‐Barbat, et al.. (2009). Ataxia telangiectasia mutated activation by transcription‐ and topoisomerase I‐induced DNA double‐strand breaks. EMBO Reports. 10(8). 887–893. 190 indexed citations
13.
Rao, V. Ashutosh, Chiara Conti, Josée Guirouilh‐Barbat, et al.. (2007). Endogenous γ-H2AX-ATM-Chk2 Checkpoint Activation in Bloom's Syndrome Helicase–Deficient Cells Is Related to DNA Replication Arrested Forks. Molecular Cancer Research. 5(7). 713–724. 76 indexed citations
14.
15.
Conti, Chiara, John H. Herrick, & Aaron Bensimon. (2007). Unscheduled DNA replication origin activation at inserted HPV 18 sequences in a HPV‐18/MYC amplicon. Genes Chromosomes and Cancer. 46(8). 724–734. 11 indexed citations
16.
Conti, Chiara, et al.. (2007). The Intra-S-Phase Checkpoint Affects both DNA Replication Initiation and Elongation: Single-Cell and -DNA Fiber Analyses. Molecular and Cellular Biology. 27(16). 5806–5818. 185 indexed citations
17.
Bersani, Giuseppe, Massimo Di Giannantonio, Alfredo Grilli, et al.. (2005). Neurologic Soft Signs in Schizophrenic Patients Treated With Conventional and Atypical Antipsychotics. Journal of Clinical Psychopharmacology. 25(4). 372–375. 24 indexed citations
18.
Herrick, John H., Chiara Conti, Sébastien Teissier, et al.. (2005). Genomic Organization of Amplified MYC Genes Suggests Distinct Mechanisms of Amplification in Tumorigenesis. Cancer Research. 65(4). 1174–1179. 33 indexed citations
19.
Zorzi, Giovanna, et al.. (2003). Paroxysmal dyskinesias in childhood. Pediatric Neurology. 28(3). 168–172. 17 indexed citations
20.
Angelini, Lucia, Nardo Nardocci, Margherita Estienne, et al.. (2000). Life-threatening dystonia-dyskinesias in a child: Successful treatment with bilateral pallidal stimulation. Movement Disorders. 15(5). 1010–1012. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raman Kumar Breakdown of academic impact, for papers by Matsuyuki Shirota Breakdown of academic impact, for papers by Xiaobing Tian Breakdown of academic impact, for papers by Lynn S. Cheng Breakdown of academic impact, for papers by Yixue Gu Breakdown of academic impact, for papers by Janice Rowe Breakdown of academic impact, for papers by Teng Ji Breakdown of academic impact, for papers by Zuzanna Tracz‐Gaszewska Breakdown of academic impact, for papers by Enyuan Shang Breakdown of academic impact, for papers by Marta Deganuto
Rankless by CCL
2026